Current Affairs

FDA OKs New Gene Therapy for Debilitating Skin Condition

(MedPage Today) – Prademagene Zamikeracel (Zevaskyn) adopted by FDA for the treatment of adults and children with scattered wounds caused by the dissolution of the skin recessive disorder. Patients …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button